H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers
Nature Medicine2018Vol. 24(4), pp. 497–504
Citations Over TimeTop 1% of 2018 papers
Michael Seiler, Akihide Yoshimi, Rachel Darman, Betty Chan, Gregg F. Keaney, Michaël Thomas, Anant A. Agrawal, Benjamin Caleb, Alfredo Csibi, E. Egan Sean, Peter Fekkes, Craig Karr, Virginia M. Klimek, George Lai, Linda Lee, Pavan Kumar, Stanley Chun-Wei Lee, Xiang Liu, Crystal MacKenzie, Carol Meeske, Yoshiharu Mizui, Eric Padron, Eunice Park, Ermira Pazolli, Shouyong Peng, Sudeep Prajapati, Justin Taylor, Teng Teng, John Wang, Markus Warmuth, Huilan Yao, Lihua Yu, Ping Zhu, Omar Abdel‐Wahab, Peter G. Smith, Silvia Buonamici
Related Papers
- → Human step II splicing factor hSlu7 functions in restructuring the spliceosome between the catalytic steps of splicing(1999)55 cited
- → SAP30BP interacts with RBM17/SPF45 to promote splicing in a subset of human short introns(2022)
- → Abstract 3482: METTL3-mediated m6A modification controls splicing factor abundance and contributes to CLL progression(2023)
- → Supplementary Figures S1-8 from METTL3-Mediated m<sup>6</sup>A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL(2023)
- → Supplementary Figures S1-8 from METTL3-Mediated m<sup>6</sup>A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL(2023)